Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

NCT01603277 is registered in ClinicalTrials.gov with Humanigen, Inc. as lead sponsor.

NCT NCT01603277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01603277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Lead sponsor
Humanigen, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
January 31, 2014
Enrollment
160 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

moderate-to-severe asthma